tirzepatide fda label confirms shortage is still over, gives compounders a grace period FDA approves new version of

Manufacturer savings programs: Eli Lilly will likely offer a savings card similar to Mounjaro's, potentially reducing out-of-pocket costs to $25$50/month for commercially insured patients Projected price: List price estimated at $1,000$1,500/month based on tirzepatide's pricing Brand name: Eli Lilly will give it a commercial brand name (similar to tirzepatide becoming "Mounjaro" and "Zepbound") For more on FDA status, trial progress, and what approval will mean for access and cost, see our guide: Is Retatrutide FDA Approved

Many providers recommend holding the weekly injection during acute gastrointestinal illness and resuming at the current dose once symptoms resolve

Insulin resistance is considered a primary driver of NAFLD pathophysiology, and insulin resistance induced hepatic steatosis, fatty acid overload and lipotoxicity result in hepatic vulnerability related to inflammation and oxidative stress

Ingredients & Dosage Inactive ingredients / formulation base Molecular Formula: C14H24N6O4Cu SKU: GHN0050MG Shipping & Storage Shipping: Orders ship within 12 business days